Literature DB >> 3019839

The fos gene product undergoes extensive post-translational modification in eukaryotic but not in prokaryotic cells.

L C Sambucetti, M Schaber, R Kramer, R Crowl, T Curran.   

Abstract

To investigate the properties of the fos oncogene, we have constructed bacterial and yeast vectors which express the entire fos-coded protein (Fos) and two C-terminal deletion products. In Escherichia coli, Fos proteins were expressed from the phage lambda pL promotor under the control of the temperature-sensitive lambda repressor. In vitro transcription/translation studies indicate that these vectors produce Fos proteins of the expected sizes. However, in vivo, Fos protein accumulation is observed only in hosts with the Lon- phenotype. In Saccharomyces cerevisiae, the fos gene was expressed from the PHO5 promoter which is induced under low-phosphate conditions. In contrast to the situation in E. coli, in which the heterologous proteins appeared as single major products when subjected to sodium dodecyl sulfate - polyacrylamide gel electrophoresis, the Fos proteins in S. cerevisiae displayed extensive Mr heterogeneity. Pulse-chase analyses indicated that this heterogeneity was a consequence of extensive post-translational modification. These modifications occurred to an equivalent extent on the products coded by the fos gene with C-terminal deletions and thus appear not to be controlled by the missing domain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019839     DOI: 10.1016/0378-1119(86)90009-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal.

Authors:  J M Miano; R R Tota; N Vlasic; K J Danishefsky; M B Stemerman
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

2.  Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly.

Authors:  C Abate; D Luk; R Gentz; F J Rauscher; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector.

Authors:  I Tratner; P De Togni; P Sassone-Corsi; I M Verma
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 4.  The expression of homologous and heterologous genes in yeast.

Authors:  A J Kingsman; C Stanway; S M Kingsman
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

5.  Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.

Authors:  J R Barber; I M Verma
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

6.  Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.

Authors:  C A Cantwell; E Sterneck; P F Johnson
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen.

Authors:  D R Cohen; T Curran
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expression.

Authors:  D D Belsham; W C Wetsel; P L Mellon
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

9.  Proteolytic response to the expression of an abnormal beta-galactosidase in Escherichia coli.

Authors:  M J Kosinski; U Rinas; J E Bailey
Journal:  Appl Microbiol Biotechnol       Date:  1992-06       Impact factor: 4.813

10.  Barium modulates c-fos expression and post-translational modification.

Authors:  T Curran; J I Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.